SoloHealth launches new pay-for-performance ad format
ATLANTA — SoloHealth on Monday announced its new pay-per-performance ad format called SoloTrigger. A permission-based advertising format, SoloTrigger delivers targeted and relevant sponsor content that allows consumers to actively request additional information regarding products or services that will help them live a healthier lifestyle, the company stated.
“Targeted and contextually relevant content is what today’s savvy consumers expect, and brands must meet those expectations to build engaged interactions that drive change in behavior,” stated Dan Bonert, VP advertising sales for SoloHealth. “Our national platform allows brands to become solutions for consumers, providing a meaningful experience with their content and an opportunity to reach health-conscious shoppers when they are engaged and interested in products that are aisles away, not miles away.”
The new ad format is served as consumers are interacting with the SoloHealth Station, an FDA-approved digital health-and-wellness kiosk, while their health and wellness is top of mind and the sponsor content is contextually relevant and targeted.
During a limited three-day trial, close to 11,000 of the 69,000 consumers that interacted with the SoloHealth Station kiosk requested additional product/service information via the new SoloTrigger ad format, representing 16% of the total audience. Based on these initial trials, an execution across SoloHealth’s nationwide footprint would yield results of more than a half a million engaged consumers actively seeking more information on products and/or services during the course of only 30 days. Sponsors only pay when consumers actively engage with the ad content.
The stations are currently located in more than 1,200 retail locations nationwide, including Sam’s Club and Walmart stores, expanding to more than 2,500 store locations by mid-2013 and 4,000 by 2014.
The SoloTrigger ad format is served through one of the SoloHealth Station’s testing paths/sessions — for example, during the BMI, blood pressure or vision screening sessions. Sponsors will have exclusivity during a set time period across the SoloHealth nationwide footprint.
Reuters: CVS/pharmacy will stock Tylenol in only half of its stores
NEW YORK — CVS/pharmacy has decided to stock Tylenol pain reliever in only half of its stores, according to a Reuters report published Monday.
According to the report, CVS will stock Tylenol in each market, but not in each store as CVS seeks to plug any out-of-stock holes left behind by the initial recall of Tylenol three years ago and the brand’s slow trek back to shelf.
Children’s Tylenol liquid suspension had been making a comeback in the past year. According to SymphonyIRI Group data for the 52 weeks ended Oct. 7, across all channels Children’s Tylenol was again the leading internal analgesic brand with $42.5 million in sales, up 27.5%. Across adult tablets, however, Tylenol is the No. 4 brand ranked behind Advil, Aleve and Bayer with a sales decline of 39.2% to $153.9 million. Private brand acetaminophen has been the big winner since Tylenol’s first recalls — sales of all private label internal analgesics totaled $1.3 billion for the 52 weeks ended Oct. 7, up 12.7%.
Perrigo had been preparing for Tylenol to reclaim its marketshare throughout 2013. "We feel the right way for us to look at [Johnson & Johnson] is we’ll take it a quarter by a quarter relative to their return to the marketplace," Perrigo chairman, CEO and president Joe Papa told analysts this past fall. "The operating assumption that we have in our business, it is continue to expect that as they return to the business that instead of our normal 90%, 91% retention rate, when the consumer makes a decision to move from national brand to store brand, … that we would retain approximately 50% of the consumers that have moved from the national brand to the store brand because they could not, there was no access to a national brand product."
"We’re looking forward to the return of the OTC products, and we know that we’re delayed in that return," J&J VP finance and CFO told analysts in October 2012. "We want to do this right. But of course we see those returning over the near term horizon in 2013. And so all in all I think the business is on sound footing. … I think the investments we made were the appropriate ones. They’re paying off," he said. "So I feel pretty good about where the business is right now."
Johnson & Johnson will be addressing analysts on Jan. 22 at 8:30 a.m. EST to discuss the company’s fiscal 2013 results.
Find us on Facebook for more information on drug store news, insights and products.
East Coast reeling from flu, bug begins making its trek west
ATLANTA — The worst of the flu season may be over, at least for those on the East Coast. In a late morning press conference with reporters on Friday, Thomas Frieden, director of the Centers for Disease Control and Prevention, said, "We are seeing a decrease in some regions."
Just don’t tell that to anyone living in New York, Boston or Chicago, at least not before slipping on a facemask first.
New York state Gov. Andrew Cuomo over the weekend declared a Public Health Emergency for all of New York State in response to this year’s increasingly severe flu season the state’s residents are experiencing right now. As of Jan. 5, people living in New York, New Jersey, Puerto Rico and the U.S. Virgin Islands were reporting an "elevated" level of out-patient influenza-like illness activity with levels approaching 6.8% of all hospital visits vs. a regional baseline of 2%. The New York State Department of Health noted that ILI activity has been reported in all 57 counties plus New York City and has been trending up 7% for the week ended Jan. 5 as compared to the week prior.
The New York governor also issued an executive order allowing pharmacists to administer pediatric flu vaccinations, suspending for the next 30 days the section of New York State Education Law that limits the authority of pharmacists to administer immunizing agents only to individuals 18 years of age or older.
“We are experiencing the worst flu season since at least 2009, and influenza activity in New York State is widespread, with cases reported in all 57 counties and all five boroughs of New York City,” Cuomo said. “Therefore, I have directed my Administration, the State Health Department and others to marshal all needed resources to address this public health emergency and remove all barriers to ensure that all New Yorkers – children and adults alike – have access to critically needed flu vaccines.”
The ensuing run on flu shots created retail supply shortages heading into this past weekend throughout Boston, the Boston Business Journal reported on Monday. Boston opened up several flu clinics across the area, serving up some 7,000 influenza vaccinations the BBJ reported.
Flu cases are now accounting for over 4% of all emergency department visits at Boston hospitals, compared to about 1% during non-influenza season.
With demand running high through New York City and Boston, a little further west in Chicago, Supervalu announced Monday it will be resupplying its Illinois-region Jewel-Osco pharmacies with some 7,000 additional influenza vaccinations. "There is still an uptick in flu incidence heading West and there is no guarantee that this season has reached its peak," the Minnesota-based supermarket retailer stated.
"Only the next week or two will show if we have in fact crossed the [peak]," noted Thomas Frieden. "As we often say — the only thing that’s predicable about the flu is that it’s unpredictable," he said.
While the East Coast has been hit particularly hard by flu incidence, the flu storm may be traveling west. "Most of the country has seen or is seeing a lot of flu. This may continue for the next few weeks," Frieden said. "It does appear that in parts of the South and Southeast it does look [as though] we’re past the peak." It’s a common progression for the flu begin its uptick across the South and Southeast and then head West, he added.
One clue that the flu is about to hit hard, at least in Hollywood, was at last night’s Golden Globe Awards. Hugh Jackman, who hugged many of Hollywood’s elite on his way to the stage to accept the award for "Best Actor" for his performance in "Les Miserables" told the audience that he was just getting over the flu and had been "kicking himself for not getting the flu shot earlier.
Actually all of California is bracing for an uptick in flu cases, Ron Chapman, director of the California Department of Public Health announced in a release on Friday. “California is seeing an accelerated increase in flu activity over the past few weeks,” he said, urging citizens to get their flu shots if they haven’t already. "California generally sees an increase in cases in late December or early January and it often peaks in February or March. According to CDPH surveillance indicators, influenza activity in California is beginning to show a steady increase," he said. “There is no shortage of vaccine in California and it is not too late to get vaccinated. Our flu season may not peak for several more weeks, so I encourage everyone to get vaccinated to protect not only themselves, but those with whom they come into contact.”
Addressing reports on vaccine shortages elsewhere, Frieden suggested that those who want to be vaccinated should still be able to locate the vaccine. "By this time of year, a lot of doctor’s offices [are out]," Frieden said. "It may be that you have to call a lot of places before you go out but it should be available for you," he suggested. "More than 130 million doses that were produced by the vaccine manufacturers this year have already been given."
And a good amount of those vaccines have been administered through retail. Toward the end of 2012, Walgreens had already administered 5 million flu shots. Before the demand for flu shots reached a frenzy, CVS/pharmacy had been projecting 3 million flu shots for the season and Rite Aid another 2 million.
There have also been spot shortages of the pediatric liquid formulation of Tamiflu, the CDC reported.
Across the front-end, on the other hand, demand for cough and cold formulations and the number of ancillary products that go with that — hand sanitizer, facial tissue — has all been high.
According to data posted online Friday, influenza-associated hospitalizations are running at a rate of 13.3 per 100,000 population. The most-affected group is over the age of 65. Among all hospitalizations, 86.2% were associated with influenza A and 13% with influenza B. Among hospitalizations with influenza A subtype information, 98.7% were attributed to H3 and 1.3% were attributed to 2009 H1N1.
As of Jan. 11, 24 states and New York City were reporting high levels of influenza-like illness, 16 states were reporting moderate levels, five states were reporting low levels, and five states reported minimal levels, including California, Connecticut, Kentucky, Maine and Montana. The region that includes Arizona, California, Guam, Hawaii and Nevada reported "normal" levels of flu incidence for the week ended Jan. 5, the CDC reported.
"The bottom line, it’s the flu season," Frieden said.
FOR MORE COVERAGE OF THE FLU EPIDEMIC CLICK HERE